Copyright: ©Author(s) 2026.
World J Nephrol. Jun 25, 2026; 15(2): 118253
Published online Jun 25, 2026. doi: 10.5527/wjn.v15.i2.118253
Published online Jun 25, 2026. doi: 10.5527/wjn.v15.i2.118253
Table 2 Immunosuppression in patients receiving early and late steroids, n (%)
| Variables | Early (n = 84) | Late (n = 44) | P value (df for χ2) |
| Induction agent | 0.54 (2) | ||
| Basiliximab | 53 (63.1) | 25 (56.8) | |
| ATG | 21 (25.0) | 15 (34.1) | |
| None | 10 (11.9) | 4 (9.1) | |
| Plasmapheresis | 28 (33.3) | 21 (47.7) | 0.11 (1) |
| Overall ATG use | 27 (32.1) | 18 (40.9) | 0.32 (1) |
| Bortezomib1 | 1 (1.2) | 4 (9.1) | 0.05 (1) |
| Mtor inhibitor | 2 (2.4) | 0 (0.0) | 0.54 (1) |
| Cyclosporine | 2 (2.4) | 1 (2.3) | 1.00 (1) |
| Azathioprine | 2 (2.4) | 3 (6.8) | 0.34 (1) |
- Citation: Roy S, Behera MR, Kaul A, Prasad N, Bhadauria DS, Patel MR, Kushwaha RS, Yachha M, Yadav P, Lal H. Comparison of infectious complications following early versus late pulse steroid therapy in renal transplant recipients. World J Nephrol 2026; 15(2): 118253
- URL: https://www.wjgnet.com/2220-6124/full/v15/i2/118253.htm
- DOI: https://dx.doi.org/10.5527/wjn.v15.i2.118253